ANNAPOLIS, Md., Jan. 10, 2025 /PRNewswire/ — Alphyn, a clinical-stage dermatology company developing first-in-class Multi-Target Therapeutics®, announced today that CEO Neal Koller will present at the following investor conferences during J.P. Morgan Healthcare Week in San Francisco next…